2m 2m 2m 2m 2m 2m 2m
Alkermes (ALKS)
NASDAQ
$48.36+$2.34 (+5.08%)
Price as of Jun 23, 2026 6:40 PM EDT- $7.6BMarket Cap
- 57.28%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Alkermes (ALKS)
$48.36+$2.34 (+5.08%)
ALKS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $46.02 | ||
Change | +$1.03 (+2.29%) | ||
Open | $45.40 | ||
High | $46.63 | ||
Low | $45.01 | ||
Previous Close | $44.99 | ||
Volume | 3,227,467 | ||
30-Day Average Volume | 2,401,769 | ||
1-Week Change | 3.74% | ||
1-Month Change | 25.05% | ||
1-Year Change | 57.28% | ||
3-Year Change | 36.84% | ||
5-Year Change | 89.85% | ||
Fundamentals | |||
Shares Outstanding | 164.8M | ||
Total Assets | $4.3B | ||
Market Cap | $7.6B | ||
Enterprise Value | $8.7B | ||
Period: QTR TTM FY | |||
Revenue | $39.5M | ||
Net Income | $16.2M | ||
Free Cash Flow | -$169.8M | ||
EBIT | $28.5M | ||
EBITDA | $47.9M | ||
Net Working Capital | $759.1M | ||
EPS | -$0.40 | ||
Enterprise Value/EBITDA | 183 | ||
Enterprise Value/Revenue | 221 | ||
P/B | 4 | ||
P/E | -115 | ||
PEG | 0 | ||
Price/Free Cash Flow | -45 | ||
Price/Operating Cash Flow | -46 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue